Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 27;1(2):e2.
doi: 10.2196/cardio.7915.

Assessing the Utility of a Novel SMS- and Phone-Based System for Blood Pressure Control in Hypertensive Patients: Feasibility Study

Affiliations

Assessing the Utility of a Novel SMS- and Phone-Based System for Blood Pressure Control in Hypertensive Patients: Feasibility Study

Robert Mattson Peters et al. JMIR Cardio. .

Abstract

Background: Although hypertension (HTN) is a major modifiable risk factor for arterial damage, blood pressure (BP) remains poorly controlled in the hypertensive population. Telemedicine is a promising adjunct intervention that may complement traditional therapies and improve adherence rates; however, current approaches have multiple barriers to entry, including the use of relatively expensive Bluetooth devices or the dependence on smart phone utilization, which tend to exclude low-income and more elderly populations.

Objective: The aim of this study was to design and implement a new phone call- and short message service text messaging-based intervention, Epharmix's EpxHypertension, in a quality improvement project that demonstrates the feasibility of this system for BP control in a family medicine setting.

Methods: We recruited 174 patients from a community clinic in St Louis from a database of patients diagnosed with HTN. An automated call or text messaging system was used to monitor patient-reported BPs. If determined to be elevated, physicians were notified by an email, text, or electronic medical record alert. Mean systolic BPs (SBPs) and diastolic BPs (DBPs) were compared at the beginning and end of 12 weeks.

Results: After 12 weeks on the system, patients with a baseline SBP of 140 mm Hg or higher reduced SBP by 10.8 mm Hg (95% CI -14.5 to -7.2, P<.001) and DBP by 6.6 mm Hg (95% CI -9.9 to -3.4, P=.002), but no significant changes were observed in overall BPs and BPs in the group with baseline SBP less than 140 mm Hg.

Conclusions: EpxHypertension provides a viable means to control HTN in patients with high baseline BPs despite previous therapy. This community implementation study demonstrates the feasibility of implementing EpxHypertension across a primary care setting without the need for smartphones or Bluetooth-linked BP cuffs. Future studies should evaluate its effectiveness in a randomized control trial compared with standard of care.

Keywords: disease management; eHealth; hypertension; mHealth; primary care; quality improvement; telemedicine; text messaging.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both Avik Som, the cofounder and the chief medical officer of Epharmix, and Jacob Groenendyk have a financial conflict of interest. All other authors report no conflicts of interest.

Figures

Figure 1
Figure 1
Study flow diagram detailing the stages of the implementation and the number of patients.
Figure 2
Figure 2
Patient satisfaction with message frequency.
Figure 3
Figure 3
Change in self-reported bimonthly average systolic blood pressures (SBPs) for all patients. No response indicates patients who did not report any BPs during the 2-week period.
Figure 4
Figure 4
Change in self-reported bimonthly average systolic blood pressures (SBPs) for patients with a baseline SBP greater than or equal to 140 mm Hg. Within the subpopulation of patients with a baseline greater than or equal to 140 mm Hg, there is a significant decline in the proportion of reported SBP averages greater than/equal to 140 mm Hg. The 44 enrolled patients who did not complete baseline analysis and illogical self-reported BPs because of SMS formatting discrepancies were excluded from the analysis. No response indicates patients who did not report any BPs during the 2-week period.

References

    1. Lilly LS, Gordon GH, Drago J. Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty. Philadelphia, PA: Lippincott Williams & Wilkins; 2016. Chapter 13: Hypertension.
    1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics Committee Stroke Statistics Subcommittee Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017 Mar 07;135(10):e146–e603. doi: 10.1161/CIR.0000000000000485. - DOI - PMC - PubMed
    1. Hebert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993 Mar 08;153(5):578–81. - PubMed
    1. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol. 1996 Apr;27(5):1214–8. doi: 10.1016/0735-1097(95)00606-0. http://paperpile.com/b/eMt7D6/lfba - DOI - PubMed
    1. Merai R, Siegel C, Rakotz M, Basch P, Wright J, Wong B, DHSc. Thorpe P. CDC grand rounds: a public health approach to detect and control hypertension. MMWR Morb Mortal Wkly Rep. 2016 Nov 18;65(45):1261–4. doi: 10.15585/mmwr.mm6545a3. doi: 10.15585/mmwr.mm6545a3. - DOI - DOI - PubMed